Stromal clues to bladder cancer progression
Official title: The stromal microenvironment as a co-organizer of bladder carcinogenesis and progression
Funded at Methodist Hospital Research Institute · NIH-11418379 · Data updated 2026-11-12
A U54 center study looks at how the bladder’s surrounding tissue shapes cancer development and uses that knowledge to identify risk markers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 22, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,681,032 |
| NIH project number | 5U54CA274375-05 |
| Project ID | NIH-11418379 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with early-stage bladder lesions (NMIBC) or those at risk of progression.
✕Less likely to help
Patients with advanced-stage disease or non-bladder cancers may not directly benefit.
What this research studies
This center project investigates how the tissue around bladder tumors influences whether non-muscle-invasive bladder cancer stays mild or progresses. Researchers aim to map the interactions between stromal cells and tumor cells to find biomarkers that can predict aggressive disease. The work will combine mechanistic studies with data- and bioinformatics-driven analyses to create a risk-stratification platform for NMIBC. The goal is to help clinicians tailor monitoring and treatment based on a patient’s unique bladder biology.
Why it matters
Potential benefit: If successful, patients could receive more accurate prognosis and personalized care plans based on tumor-stromal biology.
How similar studies have gone: Previous work in tumor microenvironment has guided biomarker discovery, but this project focuses on NMIBC-specific stromal interactions which is relatively novel.
Where this research is happening
-
Methodist Hospital Research Institute
Houston, United States Active
Researchers
- Principal investigator: Chan, Keith Syson — Methodist Hospital Research Institute
- Study coordinator: Chan, Keith Syson
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.